e-learning
resources
Vienna 2012
Monday, 03.09.2012
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Protective effect of fenspiride on bronchi in rats with COPD
N. Kuzubova, E. Lebedeva, A. Fedin, I. Dvorakovskaya (Saint Petersburg, Russian Federation)
Source:
Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session:
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session type:
Thematic Poster Session
Number:
2135
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Kuzubova, E. Lebedeva, A. Fedin, I. Dvorakovskaya (Saint Petersburg, Russian Federation). Protective effect of fenspiride on bronchi in rats with COPD. Eur Respir J 2012; 40: Suppl. 56, 2135
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Protective effect of inhaled iloprost on exercise-induced bronchoconstriction
Source: Eur Respir J 2004; 24: Suppl. 48, 443s
Year: 2004
Protective effect of inhaled glucocorticosteroids on COPD model.
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Protective effect of inhaled iloprost on specific bronchial challenge in aspirin-sensitive asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 471s
Year: 2002
Anti-inflammatory effects of targeted lung denervation in patients with COPD
Source: Eur Respir J 2015; 46: 1489-1492
Year: 2015
Persistency of antioxidant/antiinflammatory effects of erdosteine treatment in COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Acute protective effect of inhaled fluticasone on airway hyperresponsiveness to adenosine 5’-monophosphate in asthma but not in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 442s
Year: 2004
Roflumilast but not methylprednisolone inhibited cigarette smoke-induced pulmonary inflammation in guinea pigs
Source: Eur Respir J 2006; 28: Suppl. 50, 663s
Year: 2006
Protective effect of Polydexyribonucleotide against lipopolysaccharide-induced acute lung injury in rats
Source: International Congress 2017 – From respiratory muscles to acute respiratory failure
Year: 2017
Bronchial hypersensitivity and acute bronchodilatory effect of salbutamol on methacholine-induced bronchoconstriction in asthmatics with excessive airway narrowing
Source: Eur Respir J 2004; 24: Suppl. 48, 442s
Year: 2004
The effect of montelukast on the monocrotaline induced pulmonary disease in the wistar rat
Source: Eur Respir J 2004; 24: Suppl. 48, 561s
Year: 2004
Anti-inflammatory and anti-fibrotic effects of sirolimus in bleomycin-induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Inhaled roflumilast and tadalafil supress airway reactivity and inflammation in ovalbumin-sensitized guinea pigs
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
The therapeutic effects of zafirlukast on COPD induced pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 415s
Year: 2001
Anti-inflammatory effects of targeted lung denervation in patients with COPD
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014
Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009
Protective effect of chronic opisthorchiasis in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 293s
Year: 2003
The effect of the inhaled PDE4 inhibitor CHF6001 on allergen-induced inflammation in asthmatics
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Effects of corticosteroid and montelukast treatment on distal lung parenchyma and airway walls in inflammation in guinea pigs with chronic allergic inflammation
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Protective effect of inhaled anticholinergic drugs in the methacholine test
Source: Eur Respir J 2007; 30: Suppl. 51, 619s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept